Early ALS Patients Show Slowed Decline with Pridopidine Treatment
The Burden of Cognitive Dysfunction in Multiple Sclerosis
Christopher Lock, MD
Rethinking Progression in Multiple Sclerosis
Charles Turck, PharmD, BCPS, BCCCP
Switching to Risdiplam Maintains Motor Gains in SMA Patients
Ryan Quigley
CK1δ Inhibition and Riluzole in ALS: Synergy at Lower Doses
GFAP and VEGF Trajectories in Adult Type 3 Spinal Muscular Atrophy Under Nusinersen
Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care
Raphael Schneider, MD, PhD, FRCPC, CIP
Vitamin D3's Effects on Inflammatory and Oxidative Biomarkers in MS
Optimizing Vitamin D Supplementation in MS Care
How Muscarinic Therapies Are Redefining Schizophrenia Care
Michael Halassa, MD, PhD
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
Jerome Lisk, MD, MBA, M.S., FAAN
Michael Salvatore, PhD
Vicki Nejtek-Salvatore, PhD
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
Ashley Baker, MSN, PMHNP
Stephen Marder, MD
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
Tushita Mayanil, MBBS (MD)
Melanie Yabs, PharmD, MS, BCPP
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
Hannah Brown, MD
Digital Danger: Understanding AI Psychosis in Schizophrenia
Alexandria May, PharmD, BCPS
Ragy R. Girgis, MD, MS
Identifying and Managing Violence Risk in Schizophrenia Care
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.